NEW YORK (GenomeWeb) – BioGx announced today that UK-based firm Launch Diagnostics will distribute assay products from BioGx's European-based subsidiary in the UK and Ireland.

As part of the multi-year partnership, Launch Diagnostics will collaborate with the Netherlands subsidiary of Birmingham, Alabama-based BioGx to distribute its CE-IVD-marked product line for infectious diseases, in addition to laboratory-use-only products, Template Positive Controls, and ValidPaks to expedite customer validation studies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.